Pendahuluan : Glaukoma sudut terbuka primer saat ini masih merupakan kasus utama yang menyebabkan morbiditas okular di negara berkembang. Glaucoma drainage device (GDD) merupakan salah satu penatalaksanaan operasi dalam menangani kasus glaukoma. Tindakan operasi GDD memiliki faktor resiko. Erosi pada implant di konjungtiva dan tube exposed merupakan komplikasi paling sering dalam tindakan operasi GDD. Tujuan : Untuk melaporkan kasus penatalaksanaan tube exposed glaukoma implant Presentasi Kasus : Seorang pria, 50 thn datang dengan keluhan tidak nyaman pada mata kanan. Pasien memiliki riwayat operasi glaukoma implant pada mata kanan 5 tahun yang lalu. Pada pemeriksaan opftalmologis mata kanan didapatkan tube exposed disertai dengan injeksi siliar. Pasien kemudian dilakukan penatalaksanaan untuk memperbaiki glaukoma implant dengan menggunakan graft sklera pada mata kanan. Kesimpulan : Tindakan operasi GDD menjadi salah satu tindakan yang biasa dilakukan untuk penatalaksanaan glaukoma , Tube exposed pada GDD dapat di tatalaksana dengan menggunakan graft sklera.

Glaukoma primer sudut tertutup (GPSTp) adalah penyakit kerusakan pada saraf mata akibat penutupan sudut bilik anterior dengan faktor risiko utama peningkatan TIO yang menyebabkan menyempitnya lapang pandang dan menurunnya fungsi penglihatan. Tatalaksana glaukoma bertujuan untuk menurunkan TIO. Penelitian ini bertujuan untuk mengetahui karakteristik penderita GPSTp di PMN RS Mata Cicendo Bandung tahun 2020 berdasarkan jenis kelamin, sebaran wilayah, profesi, usia, keluhan utama, lateralitas, diagnosis, visus, C/D ratio, TIO, faktor risiko, penyakit penyerta, tatalaksana dan lama kontrol. Penelitian menggunakan desain cross sectional deskriptif, menggunakan data sekunder melalui data rekam medis pasien glaukoma di RS Mata Cicendo Bandung periode Januari 2020 -Desember 2020. Sampel penelitian berjumlah 176 pasien dan terdapat 290 mata yang terdiagnosis GPSTp. Hasil penelitian ini menunjukkan GPSTp lebih banyak terjadi pada perempuan (64,2%) dengan rata-rata usia 61 tahun. Mayoritas pasien didiagnosis pada dua mata (64,8%). Penurunan penglihatan (70,5%) merupakan keluhan utama terbanyak. Rata-rata TIO pasien adalah 32,7 dengan visus terbanyak di bawah 3/60 (21%). Hipertensi (40,9%) menjadi penyakit penyerta terbanyak. Medikamentosa (95,9%) diberikan pada hampir semua pasien dengan trabekulektomi menjadi pilihan tindakan terbanyak. Pasien paling banyak melakukan kontrol selama 1 bulan (36,9%) dengan kontrol selama 12 bulan memiliki rata-rata TIO pada kontrol terakhir yang paling rendah, yakni 20,36.

Background: Glaucoma is the second most common cause of blindness after cataract in the world and also in Indonesia. Based on the etiology, glaucoma is classified into primary and secondary glaucoma. Secondary glaucoma can cause severe visual function disorders and affect the patient's quality of life. This study was carried out to indentify the characteristics of new secondary glaucoma patients at Cicendo Eye Hospital from January to December 2013. Methods: This descriptive study was carried out at Cicendo Eye Hospital from November to December 2014. Secondary data were retrieved from medical records of new secondary glaucoma patients who came to the Glaucoma unit from January to December 2013. Inclusion criteria were medical records comprising data about age, gender, location of the affected eyes by secondary glaucoma, etiology of secondary glaucoma and value of intraocular pressure. The collected data were recorded and analyzed to illustrate their frequency distribution and proportion. Results: Out of 63 patients, 42.9% was 40-59 years old and 63.5% was men. Most cases were unilateral (82.5%). It was found that 74 eyes (52 unilateral, 11 bilateral), diagnosed as secondary glaucoma, had intraocular pressure ≥30 mmHg which were 54.1%. Secondary glaucoma were caused by lens induced (36.5%), inflammation (22.2%), and trauma (9.5%). Conclusions: Most cases are middle-aged patients and dominated by men. The eye diagnosed as secondary glaucoma occurred more in the unilateral eye which has intraocular pressure ≥30 mmHg and is caused by lens induced and inflammation.

Pendahuluan: Glaukoma pada anak merupakan kondisi yang berpotensi menyebabkan kebutaan. Penatalaksanaan glaukoma uveitis sulit dan menantang karena banyak mekanisme yang terlibat dalam patogenesisnya. Tujuan: Untuk melaporkan karakteristik klinis dan penatalaksanaan glaukoma uveitis pada anak dengan sindrom Blau. Laporan Kasus: Anak laki-laki berusia 13 tahun datang ke Poliklinik Glaukoma RS Mata Cicendo dengan keluhan kedua mata buram sejak 4 tahun lalu. Pasien telah didiagnosis sebagai sindroma Blau. Keluhan disertai persendian bengkak di lengan dan lutut, kulit hipopigmentasi dan bersisik. Riwayat operasi trabekulektomi mata sebelah kiri. Pemeriksaan oftalmologi menunjukkan visus ODS 1/300, tekanan intraokular OD 34mmHg dan OS 40mmHg. Segmen anterior mata kanan terdapat keratopati pita, sinekia posterior 360o, sinekia anterior perifer, dan katarak. Pada mata kiri terdapat bleb pada konjungtiva bulbar, keratopati pita, sinekia posterior, iridektomi perifer, dan katarak. Pasien didiagnosis sebagai glaukoma uveitis ODS, sindrom Blau, katarak komplikata ODS, keratopati pita ODS. Pasien diterapi dengan tetes mata timolol maleat 0.5%, brinzolamide, metilprednisolon tablet, metotreksat pre operatif. Pasien menjalani trabekulektomi, 5FU, sinekiolisis, retraktor iris, membranektomi mata kanan. Satu tahun pasca operatif tekanan intraokular pasien terkontrol, OD: 19mmHg, OS: 28mmHg dengan pemberian tetes mata timolol maleat 0.5% dan brinzolamide. Kesimpulan: Tatalaksana glaukoma uveitis pada anak membutuhkan terapi multidisiplin yang agresif dalam mengontrol inflamasi, tekanan intraokular, dan terapi ambliopia untuk mempertahankan penglihatan.

No abstract

Background: Pseudoexfoliation syndrome is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye. This condition is a major risk factor for development of glaucoma, termed pseudoexfoliation glaucoma (PEXG). The aim of this study was to describe the characteristic and management of PEXG in the National Eye Center Cicendo Eye Hospital. Methods: A descriptive retrospective study was conducted in October-November 2012 using medical records of PEXG patients in the National Eye Center Cicendo Eye Hospital during January-October 2012. Results: There were 32 patients (43 eyes) diagnosed as PEXG, most of them were male (78.1%), age 70-74 years old (34.4%) and followed by those in the range of age 65-69 years old (21.9%). Most of the cases were unilateral (65.6%) decrease of visual acuity less than 3/60 (76.7%), increase of intraocular pressure (IOP) with majority in the range of 31-40 mmHg (32.6%) and 41-50 mmHg (32.6%), Cup/Disc Ratio 0.9-1.0 (46.51%) and followed by those classified as majority which were hard to assess because of the presence of opaque media (34.89%). The type of glaucoma was open angle glaucoma (88.4%). The treatment received was a combination of two types of antiglaucoma medication and surgery IOP Conclusion: PEXG is mostly found in elderly patients. While most of the patients come with high IOP and late stage of the disease IOP

No abstract

Glaucoma is the leading cause of irreversible blindness worldwide. Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) is a new method for treatment for refractory glaucoma with lesser complications than coventional TSCPC. This study aimed to evaluate the effectiveness and safety of MP-TSCPC (IRIDEX IQ810 Laser systems, CA) for refractory glaucoma treatment. This was a retrospective study using data obtained from the medical records of patients who underwent a MP-TSCPC procedure at Cicendo National Eye Hospital from July 2018 to September 2019. The outcomes measured were success rate (IOP decreased ≥30% from baseline with or without anti glaucoma medication at first month follow up) and post-operative complications. Fifty-seven eyes from 56 patients with a mean age of 57 years old underwent MP-TSCPC with 3 month follow up. The mean pre-operative intraocular pressure (IOP) dropped from 51.8 mmHg to 36.0 mmHg at 1 month follow up and 36.8 mmHg at the final follow up, representing an IOP decrease of 31% (1 month) and 28% (3 month). There was also a decrease of anti glaucoma medication usage from 2.51 to 2.16. The overall success rate at 1 month follow up was 49% and only 5% complication were found in this study. MP-TSCPC is safe and effective for lowering IOP and decreasing the need of anti glaucoma -medications in refractory glaucoma case. Further long-term evaluation and comparison to conventional TSCPC are still necessary.